NCT06944197Not yet recruiting
Therapeutic Exercise Program of Physiotherapy Using Telerehabilitation on Chronic Phase Stroke Patients
Effectiveness of a Therapeutic Exercise Program of Physiotherapy Through the Use of Telerehabilitation on Functional Capacity for Patients With Chronic Phase Stroke: Multicenter Randomized Controlled Clinical Trial.
Source: ClinicalTrials.gov · Last updated 30 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Stroke is the main cause of physical disability in adults in Catalonia. Despite this, there is a lack of evidence on physiotherapy interventions during the chronic phase of the pathology. The objective of the study is evaluate the effectiveness of a therapeutic exercise program of Physiotherapy through the use of Telerehabilitation on functional capacity in activities of daily living in patients with stroke in chronic phase. For this purpose, the investigator conduct a multicenter randomized controlled clinical trial. A minimum of 75 participants will be recruited in three intervention groups (n=25 each group) from Primary Care Centers of the Institut Català de la Salut. The sample will be made up of people over 18 years of age with a medical diagnosis of Stroke, in a chronic phase and with physical sequelae. Research team will evaluate as the main variable the functional capacity for the management of activities of daily living (Barthel Index); as well as sociodemographic variables. Also secondary variables such as motor function (MMAS), muscle tone of affected limbs (MAS), muscle strength of affected limbs (MRC), balance (PASS), gait efficiency (WGS, 4MWT), perception of musculoskeletal pain (BPI), perception of fatigue (FSS), risk of falls (TUG), perception of quality of life (NEWSQOL), and perception of quality of life (NEWSQOL), and perception of perceived subjective change after treatment (GROC). The variables will be collected, before and after the intervention , which will consist of 30 sessions (3 sessions/10 weeks). The analysis will be using a mixed linear model (ANOVA 3X3). Significance level p\<0.05.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- First submitted
- 17 Apr 2025
- Start date
- 8 May 2025
- Primary completion date
- 15 Nov 2025
- Lead sponsor
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- Diseases
- Stroke
- NCT number
- NCT06944197
What you commit to
- Study type: Interventional
- Planned participants: 75
- From 8 May 2025 to the primary completion date, 15 Nov 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous decreased motor functional capacity with a Barthel scale score of less than 60 points
Other illness
- Undergoing other non-pharmacological physical treatments for stroke sequelae improvement and/or maintenance
Other
- Cognitive and/or language barriers that hinder the understanding of informed consent and intervention
- Participation in another clinical trial during the study period that may impact the results of the variables to be evaluated
Who the study is looking for
- Age 18 years or older
- Medical diagnosis of stroke
- Stroke condition present for more than 6 months
- Physical sequelae secondary to stroke
- Minimum score of 1 on the Medical Research Council scale for overall muscle strength of affected limbs
- Maximum score of 3 on the Modified Ashworth scale for overall muscle tone of affected limbs
- Maximum score of 4 on the Modified Rankin scale for disability
- Access to computer equipment (tablet, desktop or laptop computer, or smartphone)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.